Brief: CMS Proposes To Approve The Astar System For Ntap Funding
Q linea AB QLINEA.ST :
* CMS PROPOSES TO APPROVE THE ASTAR SYSTEM FOR NTAP FUNDING
* Q LINEA AB - Q-LINEA'S ASTAR® SYSTEM MEETS COST CRITERION
FOR
NEW TECHNOLOGY ADD-ON PAYMENT (NTAP) FUNDING
* Q LINEA AB - FUNDING WILL BE EFFECTIVE FOR THREE YEARS,
FROM
OCTOBER 2024 THROUGH SEPTEMBER 2027
* Q LINEA AB - NTAP REIMBURSEMENT WOULD BE AVAILABLE TO US
HOSPITALS FOR MEDICARE PATIENTS; PROPOSED AMOUNT IS USD 97.50
PER PATIENT
Source text for Eikon: ID:nMFNnLTZ6
Further company coverage: QLINEA.ST